Cargando…
Bioinformatics-based discovery of the urinary BBOX1 mRNA as a potential biomarker of diabetic kidney disease
BACKGROUND: Diabetic kidney disease (DKD) is the leading cause of end-stage kidney disease (ESKD) in the world. Emerging evidence has shown that urinary mRNAs may serve as early diagnostic and prognostic biomarkers of DKD. In this article, we aimed to first establish a novel bioinformatics-based met...
Autores principales: | Zhou, Le-Ting, Lv, Lin-Li, Qiu, Shen, Yin, Qing, Li, Zuo-Lin, Tang, Tao-Tao, Ni, Li-Hua, Feng, Ye, Wang, Bin, Ma, Kun-Ling, Liu, Bi-Cheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6394064/ https://www.ncbi.nlm.nih.gov/pubmed/30819181 http://dx.doi.org/10.1186/s12967-019-1818-2 |
Ejemplares similares
-
Prognostic effect of lncRNA BBOX1-AS1 in malignancies: a meta-analysis
por: Lin, Guangyao, et al.
Publicado: (2023) -
Urinary small extracellular vesicles derived CCL21 mRNA as biomarker linked with pathogenesis for diabetic nephropathy
por: Feng, Ye, et al.
Publicado: (2021) -
Urinary Podocyte-Associated mRNA profile in Various Stages of Diabetic Nephropathy
por: Zheng, Min, et al.
Publicado: (2011) -
Isolation and Quantification of MicroRNAs from Urinary Exosomes/Microvesicles for Biomarker Discovery
por: Lv, Lin-Li, et al.
Publicado: (2013) -
Oncogenic lncRNA BBOX1-AS1 promotes PHF8-mediated autophagy and elicits sorafenib resistance in hepatocellular carcinoma
por: Tao, Haisu, et al.
Publicado: (2022)